What is Pristine Surgical?
Pristine Surgical LLC operates as a single-use surgical visualization company. Its core mission is to improve patient care, safety, and the overall efficacy of surgical procedures through innovative visualization technology. The company's focus on single-use systems aims to address critical issues in healthcare settings, potentially reducing infection risks and improving procedural outcomes. This strategic direction positions Pristine Surgical within the rapidly evolving MedTech sector, where advancements in visualization are key to enabling minimally invasive techniques and enhancing surgeon performance.
How much funding has Pristine Surgical raised?
Pristine Surgical has raised a total of $33M across 2 funding rounds:
Series B
$18M
Series D
$15M
Series B (2020): $18M, investors not publicly disclosed
Series D (2022): $15M led by Ceros Capital Markets
Key Investors in Pristine Surgical
Ceros Capital Markets
Ceros Capital Markets is a global investing platform that specializes in fundraising for MedTech and Biotech companies, focusing on disruptive technologies in medical devices, robotics, and digital health. The firm primarily raises funds through Series A-D rounds for innovative companies developing non-invasive diagnostic procedures.
What's next for Pristine Surgical?
The recent major strategic investment signals a pivotal phase for Pristine Surgical, likely enabling the company to scale its operations, expand its product offerings, and further penetrate the healthcare market. This infusion of capital, part of its $33M in total financing, suggests a strong investor confidence in the company's vision and its capacity to deliver advanced surgical visualization solutions. Future developments may include broader adoption of their single-use systems in hospitals, further research and development into next-generation visualization tools, and strategic partnerships to enhance market reach and impact on patient outcomes.
See full Pristine Surgical company page
